A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder.
about
Efficacy and tolerability of second-generation antidepressants in social anxiety disorderThe noradrenergic paradox: implications in the management of depression and anxietyCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersThe evidence-based pharmacotherapy of social anxiety disorderPharmacotherapy for social anxiety disorder: a systematic review.Severe hypertriglyceridemia secondary to venlafaxine use in an older adult on dialysis -case report.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.Current management of obsessive and phobic states.Optimal treatment of social phobia: systematic review and meta-analysis.An evaluation of paroxetine in generalised social anxiety disorder.Treatment of anxiety disorders with venlafaxine XR.INFLUENCE OF STUDY DESIGN ON TREATMENT RESPONSE IN ANXIETY DISORDER CLINICAL TRIALSSecond-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials.Glutamate-based anxiolytic ligands in clinical trials.Update on the efficacy of pharmacotherapy for social anxiety disorder: a meta-analysis.Generalized social anxiety disorder: A still-neglected anxiety disorder 3 decades since Liebowitz's review.Don't ask, don't tell: a systematic review of the extent to which participant characteristics are reported in social anxiety treatment studies.A meta-analysis of pharmacotherapy for social anxiety disorder: an examination of efficacy, moderators, and mediators.Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants.Paroxetine-induced increase in LDL cholesterol levels.Pharmacotherapy for social anxiety disorder (SAnD).
P2860
Q24656009-F504D715-FAA9-400A-9C47-B2985511D700Q26752868-3F813A29-E3E1-48D3-8354-E60AA0C3BC75Q27009995-52EBF29F-FE1C-40F7-9446-9C62EA5EAA20Q28262456-FAF06177-496E-4134-B5DB-EDC7DB44D5E5Q33319625-AF0DAC7E-CF5B-4EC2-9C2D-490FA581AE3AQ33560550-DD40A4FA-1442-41CD-8BCC-BBC621462364Q34584223-16B37CB0-E705-4E71-ABE9-FE4E7D7AB7D5Q34865036-5A9534F8-D938-4E97-9841-32224556236AQ35327098-22F8D59B-92EF-444E-B100-3A739D242C71Q35997293-7D5E5FC7-C2DE-4E19-BE4A-9997019CAE4FQ36150800-9730F512-FA25-47DC-B001-B9C6A2B5732AQ36419538-2C5E6DAE-DA2B-4FAC-A68A-52E6BAFC6179Q37041164-56107B58-F1A6-4A3C-9F1D-2A5DFE7FE8D0Q37823393-57716E67-DD41-484A-ADC2-22E3468F5F59Q38110306-5EE25F48-90A6-4712-96AF-C91C79EDF94DQ38256876-BD76B6B5-347C-404E-B8BC-0387F9173B2CQ38539809-C12BB8C9-C20B-4248-B865-6DA24E0CA07DQ38686261-859A64B6-B659-4683-BE6B-2503A8670F53Q38767369-13BA93A4-B5D5-40C7-B8C2-5051A14B3810Q46182025-18409D50-744D-44F7-A4B4-BF4C82527BAAQ46202378-B943D912-CB70-4546-8714-A26308A820D2Q47593921-62350FF3-548A-4091-BED7-34C0AF838887
P2860
A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
A double-blind, placebo-contro ...... lized social anxiety disorder.
@ast
A double-blind, placebo-contro ...... lized social anxiety disorder.
@en
type
label
A double-blind, placebo-contro ...... lized social anxiety disorder.
@ast
A double-blind, placebo-contro ...... lized social anxiety disorder.
@en
prefLabel
A double-blind, placebo-contro ...... lized social anxiety disorder.
@ast
A double-blind, placebo-contro ...... lized social anxiety disorder.
@en
P2093
P1476
A double-blind, placebo-contro ...... lized social anxiety disorder.
@en
P2093
Arifulla Khan
Karl Rickels
Richard Mangano
P304
P356
10.1097/01.JCP.0000138764.31106.60
P407
P577
2004-10-01T00:00:00Z